EN
HI
Dishman Carbogen Amcis Share price
173.25
0.29 (-0.17%)NSE
BSE
Last updated on 24 Aug, 2026 | 15:54 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Dishman Carbogen Amcis share price chart
Dishman Carbogen Amcis Share Key Metrics
Volume
2.26 L
Market Cap
2716.27 CR
LTQ@LTP
15@173.25
ATP
174.96
Var Margin
26.18 %
Circuit Range
138.84-208.24
Delivery %
33.37 %
Value
3.95 CR
ASM/GSM
No
Market Lot
1
Summary
DCAL stock price is ₹173.25 as of 24 Aug, 2026. The stock intraday movement has stayed between ₹172.80 and ₹177.68, while Dishman Carbogen Amcis share price 52 week high low is ₹128.50 & ₹321.95.
In terms of trading activity, DCAL share price has recorded a volume of 2,25,970 shares. The Dishman Carbogen Amcis has a market cap of ₹156783095. The stock’s Average Traded Price (ATP) stands at ₹174.96, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 15 @ ₹173.25.
The Dishman Carbogen Amcis upper circuit limit is ₹208.24 & The Dishman Carbogen Amcis lower circuit limit is ₹138.84, with a Value of ₹3.95 CR. The Delivery Percentage for the day is 33.37%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Dishman Carbogen Amcis Resistance and Support
Pivot 175.77
Resistance
First Resistance
179.33
Second Resistance
185.13
Third Resistance
188.69
Support
First Support
169.97
Second Support
166.41
Third Support
160.61
Dishman Carbogen Amcis Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
59.32%
Mutual Fund
1.41%
Insurance
0%
Foreign Institutional Investors
6.86%
Domestic Institutional Investors
0.64%
Retail
31.76%
Others
0.01%
Total Promoters
MAR '26
59.32%
JUN '26
59.32%
Dishman Carbogen Amcis Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-14 | Quarterly Results |
| 2026-08-12 | Proposal Of Fund Raising |
| 2026-05-19 | Audited Results |
| 2026-03-18 | To consider Fund Raising |
| 2026-02-03 | Quarterly Results |
| 2025-12-27 | To consider Fund Raising |
| 2025-11-04 | Quarterly Results |
| 2025-05-21 | Audited Results |
| 2025-03-12 | To consider Fund Raising |
| 2025-02-12 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Dishman Carbogen Amcis News
Dishman Carbogen Amcis Ltd - 540701 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Dishman Carbogen Amcis has announced the availability of the audio recording for its earnings conference call, which took place on August 17, 2026. The call discussed the financial results for the quarter ended June 30, 2026 (Q1 FY27), and the recording can be accessed on the company's website.
Aug 17 2026 19:00:28
Dishman Carbogen Amcis Ltd - 540701 - Board Meeting Outcome for UN-AUDITED FINANCIAL RESULTS AND STATUTORY AUDITORS'' LIMITED REVIEW REPORT FOR THE FIRST QUARTER ENDED 30/06/2026
Dishman Carbogen Amcis reported a Q1 FY27 consolidated net loss of ₹57.88 crores, compared to a profit of ₹23.41 crores in Q1 FY26. Consolidated total income for the quarter decreased 5.05% YoY to ₹695.80 crores. The company also extended its goodwill amortization period to 99 years.
Aug 14 2026 19:57:08
Dishman Carbogen Amcis Ltd - 540701 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Dishman Carbogen Amcis will host an earnings conference call on August 17, 2026, to discuss its Q1 FY27 financial results and performance. Global CFO Harshil Dalal and CEO Stephan Fritschi will represent management.
Aug 12 2026 18:23:18
Dishman Carbogen Amcis Ltd - 540701 - Board Meeting Outcome for Board Meeting Outcome For BOARD APPROVES ISSUE OF SENIOR, SECURED, RATED, LISTED, TRANSFERABLE, REDEEMABLE, TAXABLE NON-CONVERTIBLE DEBENTURES AGGREGATING UP TO RS. 75 CRORES
Dishman Carbogen Amcis board approved the issuance of senior, secured non-convertible debentures (NCDs) aggregating up to ₹75 crore. These NCDs will be issued via private placement with a 10.00% p.a. coupon and an 18-month tenure. The debentures are secured by a 1.1x cover, including a mortgage over DIL land and a corporate guarantee.
Aug 12 2026 11:30:17
Dishman Carbogen Amcis Ltd - 540701 - Board Meeting Intimation for Considering And Approving The Proposal Of Fund Raising By Way Of Issuance Of Non-Convertible Debentures, By Way Of Private Placement, Subject To Such Regulatory Or Statutory Approvals As May Be Required
Dishman Carbogen Amcis board will convene on August 12, 2026, to evaluate and approve a proposal for fund raising. The fundraising is planned through the issuance of Non-Convertible Debentures (NCDs) via private placement, subject to regulatory approvals.
Aug 07 2026 18:06:00
Read More
Dishman Carbogen Amcis Management
| Name | Position |
|---|---|
| Deohooti J Vyas | Whole Time Director |
| Arpit J Vyas | Global Managing Director |
Dishman Carbogen Amcis Similar Stocks
Kwality Pharmaceuticals Ltd.
3452.20
91.10 (2.71%)
Advanced Enzyme Technologies Ltd.
302.35
2.35 (0.78%)
SMS Pharmaceuticals Ltd.
354.10
-2.50 (0.70%)
Solara Active Pharma Sciences Ltd.
629.10
12.20 (1.98%)
Ind-Swift Laboratories Ltd.
327.27
-2.32 (0.70%)
Hikal Ltd.
211.99
-3.62 (1.68%)
Beta Drugs Ltd.
2307.00
-20.70 (0.89%)
Panacea Biotec Ltd.
406.20
-4.90 (1.19%)
Dr Agarwals Eye Hospital Ltd.
5373.50
-21.50 (0.40%)
Sai Parenteral's Ltd.
528.75
-12.10 (2.24%)
Dishman Carbogen Amcis FAQs
The Buying Price of Dishman Carbogen Amcis share is 173.25 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Dishman Carbogen Amcis stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Dishman Carbogen Amcis, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Dishman Carbogen Amcis shares is 168.67. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Dishman Carbogen Amcis shares is 0.41. Useful to assess the stock's value relative to its book value.
To assess Dishman Carbogen Amcis’s valuation compare Sector P/E, P/B which are 68.51 & 3.33 with sector averages, along with growth rates and financial metrics.
The Market Cap of Dishman Carbogen Amcis is 2716.27 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Dishman Carbogen Amcis share price is 321.95 & 128.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Dishman Carbogen Amcis belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in DCAL
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC